These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 10394158)

  • 1. In situ replacement of infected aortic grafts with rifampicin-bonded prostheses: the Leicester experience (1992 to 1998).
    Hayes PD; Nasim A; London NJ; Sayers RD; Barrie WW; Bell PR; Naylor AR
    J Vasc Surg; 1999 Jul; 30(1):92-8. PubMed ID: 10394158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vascular surgical society of great britain and ireland: In situ replacement of infected aortic grafts with rifampicin-bonded prostheses.
    Nasim A; Hayes P; London N; Barrie WW; Bell PR; Naylor AR
    Br J Surg; 1999 May; 86(5):695. PubMed ID: 10361201
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The results of in situ prosthetic replacement for infected aortic grafts.
    Young RM; Cherry KJ; Davis PM; Gloviczki P; Bower TC; Panneton JM; Hallett JW
    Am J Surg; 1999 Aug; 178(2):136-40. PubMed ID: 10487266
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regarding "in situ replacement of infected aortic grafts with rifampicin-bonded prostheses: the Leicester experience (1992 to 1998)".
    Calligaro KD
    J Vasc Surg; 2000 Apr; 31(4):837-8. PubMed ID: 10753300
    [No Abstract]   [Full Text] [Related]  

  • 5. Does in situ replacement of a staphylococcal infected vascular graft with a rifampicin impregnated gelatin sealed Dacron graft reduce the incidence of subsequent infection?
    Vicaretti M; Hawthorne W; Ao PY; Fletcher JP
    Int Angiol; 2000 Jun; 19(2):158-65. PubMed ID: 10905800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of rifampin-soaked gelatin-sealed polyester grafts for in situ treatment of primary aortic and vascular prosthetic infections.
    Bandyk DF; Novotney ML; Johnson BL; Back MR; Roth SR
    J Surg Res; 2001 Jan; 95(1):44-9. PubMed ID: 11120634
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does in situ replacement of a staphylococcal infected vascular graft with a rifampicin impregnated gelatin sealed Dacron graft reduce the incidence of subsequent infection?
    Vicaretti M; Hawthorne W; Ao PY; Fletcher JP
    Int Angiol; 1999 Sep; 18(3):225-32. PubMed ID: 10688422
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Limitations in the use of rifampicin-gelatin grafts against virulent organisms.
    Koshiko S; Sasajima T; Muraki S; Azuma N; Yamazaki K; Chiba K; Tachibana M; Inaba M
    J Vasc Surg; 2002 Apr; 35(4):779-85. PubMed ID: 11932679
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An increased concentration of rifampicin bonded to gelatin-sealed Dacron reduces the incidence of subsequent graft infections following a staphylococcal challenge.
    Vicaretti M; Hawthorne WJ; Ao PY; Fletcher JP
    Cardiovasc Surg; 1998 Jun; 6(3):268-73. PubMed ID: 9705099
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mycotic aneurysms of the thoracic and abdominal aorta and iliac arteries: experience with anatomic and extra-anatomic repair in 33 cases.
    Müller BT; Wegener OR; Grabitz K; Pillny M; Thomas L; Sandmann W
    J Vasc Surg; 2001 Jan; 33(1):106-13. PubMed ID: 11137930
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Graft infectivity of rifampin and silver-bonded polyester grafts to MRSA contamination.
    Schmacht D; Armstrong P; Johnson B; Pierre K; Back M; Honeyman A; Cuthbertson D; Bandyk D
    Vasc Endovascular Surg; 2005; 39(5):411-20. PubMed ID: 16193213
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of major aortic graft infection: preliminary experience with total graft excision and in situ replacement with a rifampicin bonded prosthesis.
    Naylor AR; Clark S; London NJ; Sayers RD; Macpherson DS; Barrie WW
    Eur J Vasc Endovasc Surg; 1995 Feb; 9(2):252-6. PubMed ID: 7627664
    [No Abstract]   [Full Text] [Related]  

  • 13. Improved outcomes in the recent management of secondary aortoenteric fistula.
    Armstrong PA; Back MR; Wilson JS; Shames ML; Johnson BL; Bandyk DF
    J Vasc Surg; 2005 Oct; 42(4):660-6. PubMed ID: 16242551
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In situ replacement of infected vascular prostheses with rifampin-soaked vascular grafts: early results.
    Torsello G; Sandmann W; Gehrt A; Jungblut RM
    J Vasc Surg; 1993 Apr; 17(4):768-73. PubMed ID: 8464099
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term outcome after treatment of aortic graft infection with staged extra-anatomic bypass grafting and aortic graft removal.
    Seeger JM; Pretus HA; Welborn MB; Ozaki CK; Flynn TC; Huber TS
    J Vasc Surg; 2000 Sep; 32(3):451-9; discussion 460-1. PubMed ID: 10957651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In situ repair of mycotic abdominal aortic aneurysms with rifampin-bonded gelatin-impregnated Dacron grafts: a preliminary case report.
    Gupta AK; Bandyk DF; Johnson BL
    J Vasc Surg; 1996 Sep; 24(3):472-6. PubMed ID: 8808970
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment strategies and outcomes in patients with infected aortic endografts.
    Fatima J; Duncan AA; de Grandis E; Oderich GS; Kalra M; Gloviczki P; Bower TC
    J Vasc Surg; 2013 Aug; 58(2):371-9. PubMed ID: 23756338
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In situ rifampin-soaked grafts with omental coverage and antibiotic suppression are durable with low reinfection rates in patients with aortic graft enteric erosion or fistula.
    Oderich GS; Bower TC; Hofer J; Kalra M; Duncan AA; Wilson JW; Cha S; Gloviczki P
    J Vasc Surg; 2011 Jan; 53(1):99-106, 107.e1-7; discussion 106-7. PubMed ID: 21184932
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Graft infection after endovascular abdominal aortic aneurysm repair.
    Laser A; Baker N; Rectenwald J; Eliason JL; Criado-Pallares E; Upchurch GR
    J Vasc Surg; 2011 Jul; 54(1):58-63. PubMed ID: 21292428
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prosthetic graft infection, five years after ascending aortic replacement.
    Altarabsheh SE; Deo SV; Berbari E; Park SJ
    J Card Surg; 2012 Mar; 27(2):220-1. PubMed ID: 22340423
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.